Enlivex Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Enlivex Therapeutics (ENLV) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Enlivex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enlivex Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enlivex Therapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $16k | 11k | 1.42 |
| 2023-06-30 | $30k | 11k | 2.63 |
| 2023-03-31 | $69k | 19k | 3.64 |
| 2022-12-31 | $75k | 19k | 3.94 |
| 2022-03-31 | $68k | 12k | 5.57 |
| 2021-03-31 | $144k | 13k | 11.09 |